FATE
Price
$1.19
Change
-$0.02 (-1.65%)
Updated
Jun 20 closing price
Capitalization
134.69M
38 days until earnings call
NKTX
Price
$1.77
Change
-$0.05 (-2.75%)
Updated
Jun 20 closing price
Capitalization
125.59M
47 days until earnings call
Interact to see
Advertisement

FATE vs NKTX

Header iconFATE vs NKTX Comparison
Open Charts FATE vs NKTXBanner chart's image
Fate Therapeutics
Price$1.19
Change-$0.02 (-1.65%)
Volume$2M
Capitalization134.69M
Nkarta
Price$1.77
Change-$0.05 (-2.75%)
Volume$416.46K
Capitalization125.59M
FATE vs NKTX Comparison Chart in %
Loading...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FATE vs. NKTX commentary
Jun 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FATE is a Hold and NKTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 22, 2025
Stock price -- (FATE: $1.19 vs. NKTX: $1.77)
Brand notoriety: FATE and NKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FATE: 100% vs. NKTX: 80%
Market capitalization -- FATE: $134.69M vs. NKTX: $125.59M
FATE [@Biotechnology] is valued at $134.69M. NKTX’s [@Biotechnology] market capitalization is $125.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $333.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FATE’s FA Score shows that 1 FA rating(s) are green whileNKTX’s FA Score has 1 green FA rating(s).

  • FATE’s FA Score: 1 green, 4 red.
  • NKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, both FATE and NKTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FATE’s TA Score shows that 3 TA indicator(s) are bullish while NKTX’s TA Score has 3 bullish TA indicator(s).

  • FATE’s TA Score: 3 bullish, 6 bearish.
  • NKTX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, NKTX is a better buy in the short-term than FATE.

Price Growth

FATE (@Biotechnology) experienced а -6.67% price change this week, while NKTX (@Biotechnology) price change was -4.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.57%. For the same industry, the average monthly price growth was +27.78%, and the average quarterly price growth was +14.34%.

Reported Earning Dates

FATE is expected to report earnings on Jul 30, 2025.

NKTX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+9.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($135M) has a higher market cap than NKTX($126M). FATE (-27.879) and NKTX (-28.916) have similar YTD gains . NKTX has higher annual earnings (EBITDA): -122.8M vs. FATE (-168.28M). NKTX has more cash in the bank: 266M vs. FATE (240M). NKTX has less debt than FATE: NKTX (78.9M) vs FATE (83.3M). FATE has higher revenues than NKTX: FATE (13.3M) vs NKTX (0).
FATENKTXFATE / NKTX
Capitalization135M126M107%
EBITDA-168.28M-122.8M137%
Gain YTD-27.879-28.91696%
P/E RatioN/AN/A-
Revenue13.3M0-
Total Cash240M266M90%
Total Debt83.3M78.9M106%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
42

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FATENKTX
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 18 days ago
85%
Bullish Trend 11 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SVFKX75.770.32
+0.42%
Smead Value R2
CGACX10.68-0.03
-0.28%
Calvert Global Energy Solutions C
TEEFX76.73-0.40
-0.52%
T. Rowe Price Tax-Efficient Equity I
RPMYX12.06-0.07
-0.58%
Reinhart International PMV Advisor
LIDAX9.27-0.06
-0.64%
Lord Abbett International Value A

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with CRBU. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
-2.75%
CRBU - NKTX
52%
Loosely correlated
+4.69%
BEAM - NKTX
50%
Loosely correlated
-1.35%
FATE - NKTX
48%
Loosely correlated
-1.65%
IPSC - NKTX
47%
Loosely correlated
-0.77%
TERN - NKTX
46%
Loosely correlated
-2.50%
More